Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001774292 | SCV002002110 | uncertain significance | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004738373 | SCV005367686 | uncertain significance | PIEZO2-related disorder | 2024-09-03 | no assertion criteria provided | clinical testing | The PIEZO2 c.2161C>G variant is predicted to result in the amino acid substitution p.Leu721Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0069% of alleles in individuals of European (non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |